검색
검색 팝업 닫기

Ex) Article Title, Author, Keywords

Article

Case Report

Clinical Pain 2021; 20(2): 135-140

Published online December 31, 2021 https://doi.org/10.35827/cp.2021.20.2.135

Copyright © Korean Association of Pain Medicine.

Musculocutaneous and Median Neuropathy after MiraDry Procedure for Axillary Hyperhidrosis

다한증 치료 기구인 MiraDry에 의한 근피 및 정중신경 손상 증례

Youngmin Kim, M.D., Mi-Jeong Yoon, M.D., Sunha Park, M.D. and Min Wook Kim, M.D., Ph.D.

김영민ㆍ윤미정ㆍ박선하ㆍ김민욱

Department of Rehabilitation Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea

가톨릭대학교 의과대학 인천성모병원 재활의학교실

Received: August 12, 2021; Revised: October 12, 2021; Accepted: October 22, 2021

Abstract

MiraDry®, a microwave thermolysis device, is comparably new non-surgical agent in the field of eradication of sweat glands for treating axillary hyperhidrosis and osmidrosis. So far, altered sensation, swelling, and compensatory sweating are widely known as adverse effects of MiraDry®. Of the few reported MiraDry®-induced neuropathy cases, median and ulnar neuropathies are common. Although, one case has described radial nerve and posterior cord damage with maximized stimulation intensity, musculocutaneous nerve damage induced by MiraDry® has not been reported. Here, we report a case of a 30-year-old woman experiencing left hand weakness after receiving MiraDry® at a local dermatology clinic. Left brachial plexopathy, mainly involving the median nerve and the musculocutaneous nerve with partial axonotmesis, was confirmed by electrodiagnostic studies. Ultrasound evaluation showed corresponding results. This is the first case report of the musculocutaneous neuropathy by MiraDry®.

KeywordsMiraDry?, Musculocutaneous neuropathy, Ultrasound

Korean Association of Pain Medicine

Vol.22 No.2
December 2023

eISSN: 2765-5156

Frequency: Semi Annual

Current Issue   |   Archives

Stats or Metrics

Share this article on :

  • line